NDNF
Basic information
Region (hg38): 4:121035612-121073021
Previous symbols: [ "C4orf31" ]
Links
Phenotypes
GenCC
Source:
- Kallmann syndrome (Supportive), mode of inheritance: AD
- hypogonadotropic hypogonadism 25 with anosmia (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Hypogonadotropic hypogonadism 25 with anosmia | AD | Endocrine | In Hypogonadotropic hypogonadism, surveillance in adolescence related to sexual maturation is indicated, as is monitoring of bone mineral density in order to allow early detection and treatment of disease; In order to induce and maintain secondary sex characteristics, gradually increasing doses of gonadal steroids (females: estrogen/progestin; males: testosterone/hCG) can be beneficial; Related to fertility, endocrinologic therapy (females: recombinant hCG or pulsatile GnRH therapy; males: hCG/HMG/recombinant FSH or pulsatile GnRH therapy) may be effective, though IVF may be required | Endocrine; Genitourinary; Neurologic | 20301509; 31883645 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NDNF gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 19 | 21 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 1 | 19 | 2 | 5 |
Variants in NDNF
This is a list of pathogenic ClinVar variants found in the NDNF region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-121036278-T-C | not specified | Uncertain significance (Dec 17, 2023) | ||
4-121036286-A-G | not specified | Uncertain significance (Feb 28, 2023) | ||
4-121036404-G-A | Hypogonadotropic hypogonadism 25 with anosmia | Benign (Sep 05, 2021) | ||
4-121036509-T-C | not specified | Uncertain significance (Jun 11, 2024) | ||
4-121036565-C-T | Hypogonadotropic hypogonadism 25 with anosmia | Pathogenic (Apr 07, 2020) | ||
4-121036579-T-C | Hypogonadotropic hypogonadism 25 with anosmia | Benign (Sep 05, 2021) | ||
4-121036716-C-T | not specified | Likely benign (Oct 18, 2021) | ||
4-121036734-G-A | not specified | Uncertain significance (May 01, 2022) | ||
4-121036749-G-C | not specified | Uncertain significance (Aug 19, 2023) | ||
4-121036811-AT-A | Hypogonadotropic hypogonadism 25 with anosmia | Likely pathogenic (Aug 13, 2021) | ||
4-121036936-T-G | Hypogonadotropic hypogonadism 25 with anosmia | Benign (Sep 05, 2021) | ||
4-121036950-T-C | not specified | Uncertain significance (Jan 09, 2024) | ||
4-121036995-C-T | not specified | Uncertain significance (Nov 01, 2022) | ||
4-121037016-T-C | not specified | Likely benign (Apr 23, 2024) | ||
4-121037032-A-G | Hypogonadotropic hypogonadism 25 with anosmia | Benign (Sep 05, 2021) | ||
4-121037048-G-A | not specified | Uncertain significance (Apr 19, 2023) | ||
4-121037070-C-T | not specified | Uncertain significance (Jun 09, 2022) | ||
4-121037075-A-G | not specified | Uncertain significance (Mar 07, 2024) | ||
4-121037092-T-C | not specified | Uncertain significance (Mar 15, 2024) | ||
4-121037129-T-A | not specified | Uncertain significance (May 28, 2024) | ||
4-121037146-T-G | Hypogonadotropic hypogonadism 25 with anosmia | Uncertain significance (Jul 16, 2023) | ||
4-121037198-G-A | not specified | Uncertain significance (Oct 27, 2021) | ||
4-121037201-A-G | not specified | Uncertain significance (Dec 02, 2022) | ||
4-121037318-T-C | not specified | Uncertain significance (Jun 03, 2022) | ||
4-121037321-T-A | not specified | Uncertain significance (Nov 27, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NDNF | protein_coding | protein_coding | ENST00000379692 | 3 | 37409 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.380 | 0.619 | 125725 | 0 | 9 | 125734 | 0.0000358 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.483 | 275 | 298 | 0.921 | 0.0000153 | 3731 |
Missense in Polyphen | 60 | 78.36 | 0.76569 | 957 | ||
Synonymous | -0.104 | 119 | 118 | 1.01 | 0.00000630 | 1103 |
Loss of Function | 3.04 | 4 | 17.9 | 0.224 | 8.22e-7 | 250 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000126 | 0.000123 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000444 | 0.0000440 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Promotes matrix assembly and cell adhesiveness (By similarity). Promotes neuron migration, growth and survival as well as neurite outgrowth (PubMed:20969804). Promotes endothelial cell survival, vessel formation and plays an important role in the process of revascularization through NOS3-dependent mechanisms (PubMed:24706764). {ECO:0000250|UniProtKB:Q8C119, ECO:0000269|PubMed:20969804, ECO:0000269|PubMed:24706764}.;
Recessive Scores
- pRec
- 0.110
Intolerance Scores
- loftool
- rvis_EVS
- -0.67
- rvis_percentile_EVS
- 15.86
Haploinsufficiency Scores
- pHI
- 0.615
- hipred
- Y
- hipred_score
- 0.544
- ghis
- 0.522
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ndnf
- Phenotype
Zebrafish Information Network
- Gene name
- ndnf
- Affected structure
- neurocranium
- Phenotype tag
- abnormal
- Phenotype quality
- morphology
Gene ontology
- Biological process
- angiogenesis;neuron migration;response to ischemia;nitric oxide mediated signal transduction;positive regulation of cell-substrate adhesion;positive regulation of neuron projection development;peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan;extracellular matrix organization;negative regulation of neuron apoptotic process;vascular wound healing;cellular response to hypoxia;negative regulation of endothelial cell apoptotic process
- Cellular component
- extracellular region;extracellular matrix
- Molecular function
- glycosaminoglycan binding;heparin binding